| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +65K | 100% | $0.76 | +$49.3K |
| Sells | 0 | ||||
| Net | +3 | +65K | 100% | +$49.3K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Phillip Schwartz | President of R&D, Director | $601K | Jan 20, 2022 | ||
| Gerald M. Lieberman | Director | $231K | +$17K | +7.95% | Aug 27, 2024 |
| Miranda Jayne Toledano | Chief Executive Officer, Director | $110K | +$17K | +18.4% | Jul 31, 2024 |
| Dana Yaacov-Garbeli | Chief Financial Officer | $85.9K | Apr 19, 2024 | ||
| Gregory Burshtein | Chief of R&D | $74.4K | May 28, 2024 | ||
| Hillel Galitzer | Chief Operating Officer | $63.6K | Apr 19, 2024 | ||
| Haya Taitel | Director | $34.8K | +$15.3K | +78.3% | Aug 27, 2024 |
| Ramesh Ratan | U.S.based CFO | $9.9K | Jan 19, 2022 | ||
| Spiros Jamas | Chief Executive Officer | $9.9K | Jan 18, 2022 | ||
| Yonatan Malca | Director | Aug 27, 2024 | |||
| Ron Mayron | Director | Jan 1, 2024 | |||
| Arthur C. Santora II | Chief Medical Officer | Apr 24, 2023 | |||
| Gerald M. Ostrov | Director | Aug 27, 2024 | |||
| Roger Garceau | Director | Jan 1, 2024 | |||
| Sean Ellis | Director | Aug 27, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|